Skip to main content

Xmas appeal

Support life-saving heart research and spare families from the heartache of stroke

Donate today

This pilot study will seek to find biomarkers for blood clot risks in patients who have been given the AstraZeneca COVID-19 vaccine. Patients will be screened 10 days after their first injection to determine their risk of developing a rare blood clot from the vaccine. This study will help increase understanding of why some people are more susceptible to blood clotting, which could allow them to take a preventative treatment to protect them from blood clots.

Support life-saving heart research and…

Donate today